The treatment burden: is it all getting too much?
8 February 2023
Winter 2023
The effort, cost and logistics of managing treatment for eye conditions can have a big impact on patients’ quality of life. What can be done to minimise their treatment burden?
The idea that the “treatment burden” affects a patient’s adherence to medications, adaptations and attending ongoing appointments, and is linked to worse medical outcomes, is emerging in healthcare literature (Alsadah et al, 2022). A wide range of chronic eye conditions and comorbidities with other diseases can have an impact on a patient’s quality of life. From drops and lasers for primary open angle glaucoma to intravitreal injections for eye conditions such as diabetic macular oedema, treatment burden can be relevant to a variety of medical interventions.
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
The Westminster government has launched a consultation on its 10 Year Health Plan to fix the NHS in England.
They are also calling for urgent implementation in Phase One of the 10 Year Plan.
We have responded to a green paper on prevention public from the Department of Health and Social Care.